Newscast – Page 100 – media

Boehringer, Vanderbilt U to develop cancer MCL1 inhibitors in third team-up

Cancer cells are different from normal cells in that they can avoid a naturally programmed cell death process known as apoptosis and grow almost indefinitely. In their third collaboration, Boehringer Ingelheim and Vanderbilt University have their eyes on a target that helps cancer cells evade death.
- Source: fiercebiotech
- 467
- March 16, 2018
apoptosis Company Insight MCL1
Researchers in aging tie genes to brain degeneration

As brain cells age, they lose their ability to perform basic functions, often leading to dementia and other neurodegenerative disorders. But what’s behind this decline, and can it be stopped? Two new studies out this week uncover links between genes and brain-cell functioning that could provide new targets for therapies aimed at neurodegenerative diseases.
- Source: fiercebiotech
- 483
- March 16, 2018
Dementia neurodegenerative Researches
New guidelines recommend hysteroscopy test for heavy periods

More women in England and Wales are to be offered a test to better determine the causes of heavy menstrual bleeding, on updated guidelines from the National Institute for Health and Care Excellence.
- Source: pharmatimes
- 421
- March 16, 2018
Hysteroscopy menstrual bleeding Researches
First step in development of pill-based vaccines

Researchers from Cardiff University have created the world’s first synthetic, non-biologic vaccine.
- Source: cardiff.ac.uk
- 533
- March 16, 2018
influenza vaccine non-biologic Researches
OWLSTONE MEDICAL RAISES $15 MILLION USD (£11 MILLION GBP) WITH HORIZONS VENTURES AND AVIVA

SBRI Healthcare alumni and Cambridge-based Owlstone Medical has announced that it has raised $15 million (£11 million) to drive the global commercialisation of its Breath Biopsy® platform.
- Source: eahsn.org
- 588
- March 16, 2018
Breath Biopsy® platform lung cancer Market Views
Crinetics Pharmaceuticals Snags $63.5 Million in Series B Funding

Five months after its lead drug began Phase I testing San Diego-based Crinetics Pharmaceuticals Inc has secured $63.5 million in Series B financing.
- Source: biospace
- 435
- March 16, 2018
acromegaly Market Views serise
Takeda looks east for another Entyvio growth spurt

Takeda's inflammatory bowel disease treatment Entyvio has already been delivering blockbuster-plus sales, and the Japanese drugmaker sees fertile territory for more growth in the Asia-Pacific region.
- Source: fiercepharma
- 539
- March 15, 2018
bowel Company Insight Entyvio
Cancer Researck UK links with Ideaya on PARG inhibitors

Cancer Research UK is partnering with US biotech Ideaya Biosciences to develop small molecule inhibitors of Poly(ADP-ribose) glycohydrolase (PARG).
- Source: pharmatimes
- 515
- March 15, 2018
glycohydrolase inhibitor Market Views
Participants in rogue herpes vaccine research take legal action

Three people injected with an unauthorized herpes vaccine by a Southern Illinois University researcher have filed suit against his company, demanding compensation for alleged adverse side effects from the experiments.
- Source: fiercepharma
- 623
- March 15, 2018
herpes Researches vaccine
Aspirin prevents venous thromboembolism following major orthopedic surgeries, study finds

A multicentre, double-blind, randomized, controlled clinical trial of patients who underwent total hip or knee replacement surgery showed that aspirin was as effective as rivaroxaban, the standard anti-coagulation medication, at preventing post-operative venous thromboembolism (VTE).
- Source: Medicalxpress
- 463
- March 15, 2018
aspirin Researches

your submission has already been received.

OK

Subscribe

Please enter a valid Email address！

Submit

The most relevant industry news & insight will be sent to you every two weeks.

more

more

Customer Services
Contact Us
Help Center

Buy on Drugdu.com
Browse Product Categories

Free APP

Follow Us

Terms & Conditions | Privacy Policy

粤ICP备16008861号

Copyright © 2016-2018 Drugdu.com. All Rights Reserved.